Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
TEVA REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
Analysts see upside in Teva share price - גלובס
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva and OncoGenex announce top-line survival results of Phase III SYNERGY trial evaluating custirsen in combination with first-line docetaxel and prednisone - Drug Target Review